Purchase Order 36C26026P0117
- Not listed
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 23 for a TAVR (transcatheter aortic valve replacement) kit prosthetics delivery on October 24, 2025. The contract, valued at $34,000, is not subject to any set-aside designation and is scheduled for completion by October 28, 2025. The award supports the Department of Veterans Affairs'...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, has been awarded a firm fixed-price purchase order by Veterans Integrated Service Network 4 for a Transcatheter Heart Valve System valued at $34,000. The contract, awarded on November 18, 2025, with an ultimate completion date of November 18, 2026, represents a no-set-aside procurement supporting the Department of Veterans Affairs' mission to deliver advanced...
- The Department of Veterans Affairs (VA) awarded a $97,500 firm fixed-price purchase order to Edwards Lifesciences LLC, a for-profit limited liability company, for the provision of Transcatheter Aortic Valve Replacement (TAVR) prosthetics. This contract supports the VA's Veterans Health Administration (VHA) operations within Veterans Integrated Service Network 21. Edwards Lifesciences LLC is a subsidiary of Edwards Lifesciences Corporation, a global leader in medical devices for structural...
- This contract award to Edwards Lifesciences LLC, a limited liability company subsidiary of Edwards Lifesciences Corporation, provides transcatheter aortic valve replacement (TAVR) prosthetics and related services to the U.S. Department of Veterans Affairs (VA) and Veterans Health Administration (VHA). The $113,000.00 firm fixed price purchase order has an ultimate completion date of September 2, 2024. The award is part of the VA-VHA's efforts to support cardiovascular care for veterans through...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leading provider of transcatheter and surgical cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 on October 31, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, is not set-aside and will be performed in Minneapolis, Minnesota, with an ultimate completion date of December 30, 2025. As the sole...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $32,500 firm fixed-price purchase order to Edwards Lifesciences LLC on November 3, 2025, for transcatheter aortic valve replacement (TAVR) surgical implants and prosthetics. The contract has no set-aside designation and is scheduled for completion by February 2, 2026, with performance taking place in San Francisco, California. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a...
- Edwards Lifesciences LLC received a $68,000 firm fixed-price purchase order from Veterans Integrated Service Network 1 (VISN 1), a civilian component of the U.S. Department of Veterans Affairs, for the procurement of TAVR (transcatheter aortic valve replacement) heart valves. The contract, awarded on November 3, 2025, is scheduled for completion by February 3, 2026, with performance taking place in Irvine, California. This purchase order represents a non-set-aside award and carries no...
- Edwards Lifesciences LLC, a leading cardiovascular medical device manufacturer and subsidiary of Edwards Lifesciences Corporation, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network (VISN) 22 for prosthetic emergency heart valves. The contract, awarded on November 6, 2025, with performance in Irvine, California, carries a completion date of December 31, 2025. This award represents a non-set-aside procurement through the Department of...
- The U.S. Department of Veterans Affairs (VA) awarded a $45,000.00 firm fixed price purchase order contract to Edwards Lifesciences LLC, a for-profit limited liability company, for the delivery of prosthetic transcatheter aortic valve replacement (TAVR) devices. The contract has an ultimate completion date of February 22, 2025. Edwards Lifesciences LLC is a small disadvantaged business that has received numerous prime contract awards from the VA and Veterans Health Administration (VHA) to provide...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical device innovation, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 on November 7, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, will be performed in Minneapolis, Minnesota with an ultimate completion date of November 10, 2025. This award carries no set-aside designation and...
Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order contract by Veterans Integrated Service Network 20 on November 12, 2025, for prosthetics related to transcatheter aortic valve replacement (TAVR) technology. The contract, valued at $136,000 with an ultimate completion date of November 11, 2026, will be performed in Irvine, California. No set-aside designation was used for this procurement. As the prime contractor and sole manufacturer of the required heart valve products, Edwards Lifesciences LLC will supply specialized cardiovascular medical devices to support veteran healthcare services across the VA system. This purchase order represents a continuation of Edwards Lifesciences LLC's established relationship with the Department of Veterans Affairs, which has consistently relied upon the company's advanced cardiovascular technologies across multiple Veterans Integrated Service Networks. The contract aligns with the VA's mission to provide high-quality medical care to veterans and reflects the critical nature of specialized cardiac devices in supporting surgical procedures. Edwards Lifesciences LLC's position as the sole-source provider underscores the specialized and proprietary nature of transcatheter heart valve technology required for veteran patient care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $136.0k | 11/21/25 |